Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.
about
Chemotherapy for advanced, recurrent or metastatic endometrial carcinomaSystemic therapy for recurrent, persistent, or metastatic cervical cancer: a clinical practice guideline.Anthracycline-based chemotherapy in metastatic endometrial carcinoma: an update.An update on the pharmacotherapy for endometrial cancer.Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapy.
P2860
Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Phase III comparison of methot ...... ma of the uterine endometrium.
@ast
Phase III comparison of methot ...... ma of the uterine endometrium.
@en
type
label
Phase III comparison of methot ...... ma of the uterine endometrium.
@ast
Phase III comparison of methot ...... ma of the uterine endometrium.
@en
prefLabel
Phase III comparison of methot ...... ma of the uterine endometrium.
@ast
Phase III comparison of methot ...... ma of the uterine endometrium.
@en
P2093
P1433
P1476
Phase III comparison of methot ...... ma of the uterine endometrium.
@en
P2093
Carl G Kardinal
Daniel A Nikcevich
Edward J Wos
Gary L Keeney
Harry J Long
John W Kugler
Karl C Podratz
Kendrith M Rowland
Robert A Nelimark
Vera Suman
P304
P356
10.1016/J.YGYNO.2005.08.021
P407
P577
2005-09-26T00:00:00Z